Are TBRG, OGN, MDV Obtaining Fair Deals for their Shareholders?
Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN
Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN
Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals' Hormone-Free Intrauterine Device
Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19
Organon wins US approval to widen use of arthritis biosimilar drug
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH?
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Organon & Co. (OGN)
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Orogen Reports Strong Q1 2026 Results with 144% Growth in Net Income
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon to Present New Research on Access and Value at ISPOR 2026
Organon to Present New Research on Access and Value at ISPOR 2026
Orogen Royalties Appoints Mr. Chad Wells to the Board of Directors
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—OGN, MMTX, VRE, and ESQ
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Organon (OGN) Q1 Earnings and Revenues Miss Estimates
Organon Reports Results for the First Quarter Ended March 31, 2026
Organon Cancels First Quarter Earnings Call
Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN
Orogen Royalties Reports Record Revenue and Strong Earnings Growth in 2025
Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders
Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders?
Johnson Fistel Investigates Potential Breaches of Fiduciary Duty in Connection with the Proposed Acquisition of Organon by Sun Pharmaceutical
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Organon & Co. (NYSE: OGN)
Stock Market Today (LIVE): Tehran's Hormuz Proposal and a Packed Magnificent Seven Earnings Week Give Investors Two Big Stories to Watch
Organon (OGN) Soars 30.9%: Is Further Upside Left in the Stock?
Stock Futures Subdued by Geopolitical Uncertainty
Stock Market Today: Dow Futures Fall, S&P 500 Gains As Trump Halts Iran Talks— Organon, SAP, Cheetah Net Supply Chain Service In Focus (UPDATED)
OGN Stock Alert: Halper Sadeh LLC is Investigating Whether Organon & Co. is Obtaining a Fair Price for its Shareholders
Organon Stock Soars After Sun Seals Takeover. Why Pharma M&A Is a Hot Play.
Shareholder Alert: Ademi LLP investigates whether Organon & Co. is obtaining a Fair Price for Public Shareholders
Organon To Be Acquired By Sun Pharma In $11.75B Deal, OGN Stock Spikes Nearly 17% On Robinhood 24-Hour Market
Why is Sun Pharma betting $11.75B on a struggling US drugmaker?
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical to Acquire Organon Valued at $11.75 Billion
Sun Pharma to acquire Organon in $11.75 bln all-cash deal
Sun Pharma signs Definitive Agreement to Acquire Organon
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) Rises Higher Than Market: Key Facts